Search


Current filters:


Clear current filters  or Add more filters

View Option



Results 1-10 of 24 (Search time: 0.003 seconds).

  Increased activity of platelet-activating factor acetylhydrolase in low-density lipoprotein subfractions induces enhanced lysophosphatidylcholine production during oxidation in patients with heterozygous familial hypercholesterolaemia (Journal article)

  Increased activity of PAF-acetylhydrolase in low density lipoprotein subfractions induces enhanced lysophosphatidylcholine production in patients with heterozygous familial hypercholesterolemia (Journal article)

  Increased serum levels of interleukin-1beta in the systemic circulation of patients with essential hypertension: additional risk factor for atherogenesis in hypertensive patients? (Journal article)

  Increased platelet reactivity to the aggregatory effect of platelet activating factor, in vitro, in patients with heterozygous familial hypercholesterolaemia (Journal article)

  Serum Lp(a) levels in patients with moderate renal failure (Journal article)

  Lipoprotein (a), apolipoprotein (a), phenotype and thyroid autoimmunity in patients with renal failure (Journal article)

  Plasma and Lp(a)-associated PAF-acetylhydrolase activity in uremic patients undergoing different dialysis procedures (Journal article)

  Lp(a) levels in patients with mild/moderate renal failure (Journal article)

  Lp(a) levels are different in patients with various types of primary hyperlipidemia (Journal article)

  Current methodologies for the estimation of LDL-cholesterol in hemodialysis patients, based on homogeneous HDL-C, homogeneous LDL-C, immunoseparation LDL-C and ApoB assays (Journal article)